The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Ipsen; Novartis; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Ferring; Novartis; Sanofi
Research Funding - Novartis; Pfizer

Efficacy and safety of sequential use of everolimus in patients with metastatic renal cell carcinoma previously treated by bevacizumab with or without interferon therapy: Results from pooled analysis of AVATOR, CHANGE, and TRAIN studies.
 
Antoine Thiery- Vuillemin
No Relationships to Disclose
 
Aline Guillot
No Relationships to Disclose
 
Thomas Steiner
No Relationships to Disclose
 
Edwin Herrmann
No Relationships to Disclose
 
Konstantinos N. Syrigos
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Roche
 
Nadia Kelkouli
Employment - Novartis
 
Agnese Cattaneo
Employment - Novartis
 
Thierry Nguyen
No Relationships to Disclose